MARKET

XGN

XGN

Exagen Inc.
NASDAQ
4.050
0.000
0.00%
Opening 09:30 03/25 EDT
OPEN
4.050
PREV CLOSE
4.050
HIGH
4.050
LOW
4.050
VOLUME
860
TURNOVER
--
52 WEEK HIGH
6.22
52 WEEK LOW
1.300
MARKET CAP
72.49M
P/E (TTM)
-4.8772
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XGN last week (0317-0321)?
Weekly Report · 1d ago
Weekly Report: what happened at XGN last week (0310-0314)?
Weekly Report · 03/17 09:50
EXAGEN INC. (Exact name of registrant as specified in its charter)" This is a Form 10-K filing with the Securities and Exchange Commission (SEC), which is an annual report of Exagen Inc.'s financial condition and results of operations for the fiscal year ended December 31, 2024.
Press release · 03/11 21:35
Exagen Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters · 03/11 13:32
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 03/11 13:15
EXAGEN DIAGNOSTICS Earnings Results: $XGN Reports Quarterly Earnings
NASDAQ · 03/11 12:30
Exagen GAAP EPS of -$0.20 beats by $0.03, revenue of $13.66M misses by $0.19M
Seeking Alpha · 03/11 12:04
*Exagen: On Track for Positive Adjusted Ebitda in 4Q 2025 >XGN
Dow Jones · 03/11 12:02
More
About XGN
Exagen Inc. is a provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision-making. The Company has developed and is commercializing a portfolio of testing products, under its AVISE brand. It commercially launched its testing product, AVISE CTD, which enables differential diagnosis for patients presenting with symptoms indicative of a variety of connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The comprehensive nature of AVISE CTD allows for the testing of various relevant biomarkers in one convenient blood draw. Included in AVISE CTD is its proprietary AVISE Lupus test, which enables the diagnosis of systemic lupus erythematosus (SLE) based on levels of erythrocyte bound C4d (EC4d) and B cell C4d (BC4d); along with anti-nuclear antibodies (ANA) and double-stranded DNA antibodies (ds-DNA). AVISE Lupus provides rheumatologists and their patients with sensitive and specific results.

Webull offers Exagen Inc stock information, including NASDAQ: XGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XGN stock methods without spending real money on the virtual paper trading platform.